Clinical Trials
3 trialsNCT00070499 2026-05-29
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT05413915 2026-05-29
Asciminib Used in Consolidation With Imatinib vs. Imatinib to Achieve TFR in CP-CML
Sir Mortimer B. Davis - Jewish General Hospital
Phase 3 Terminated
NCT04877522 2026-05-11
Asciminib Roll-over Study
Novartis
Phase 4 Recruiting